`Filed: October 22, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`INNOPHARMA LICENSING, INC., INNOPHARMA LICENSING LLC,
`INNOPHARMA INC., INNOPHARMA LLC,
`MYLAN PHARMACEUTICALS INC., and MYLAN INC.,
`Petitioner
`v.
`
` SENJU PHARMACEUTICAL CO., LTD., BAUSCH & LOMB, INC., and
`BAUSCH & LOMB PHARMA HOLDINGS CORP.,
`Patent Owner
`_________________
`Case IPR2015-00902 (Patent 8,669,290 B2)
`Case IPR2015-00903 (Patent 8,129,431 B2)1
`
`
`
`
`
`
`
`PATENT OWNER’S NOTICE OF CROSS-EXAMINATION OF
`DR. PAUL A. LASKAR, Ph.D.
`
`
`
`
`
`
`
`
`
`1 A word-for-word identical paper has been filed in each proceeding identified in
`the heading.
`
`
`
`
`
`
`
`Case IPR2015-00902 (Patent 8,669,290 B2)
`Case IPR2015-00903 (Patent 8,129,431 B2)
`
`Pursuant to 37 C.F.R. § 42.53, Patent Owner SENJU PHARMACEUTICAL
`
`
`
`CO., LTD. et al. (“Senju”), by and through its attorneys, will conduct a cross-
`
`examination by deposition of Dr. Paul A. Laskar regarding his declarations
`
`submitted in IPR2015-00902 and IPR2015-00903. Dr. Laskar’s cross-examination
`
`will take place, as agreed by counsel for the parties, on November 4, 2015,
`
`commencing at 9:00 a.m. (local time), at the offices of Alston & Bird-Charlotte,
`
`Bank of America Plaza, 101 South Tryon Street, Suite 4000, Charlotte, NC 28280.
`
`Counsel for Petitioners has represented that Dr. Laskar is willing to appear at the
`
`time and location indicated above.
`
`The cross-examination will take place before a Notary Public or other officer
`
`authorized by law to administer oaths. It will be recorded using at least audiotape
`
`and/or stenographic means. Senju also intends to video record the cross-
`
`examination of Dr. Laskar. The arrangements for the reporter and videographer
`
`will be made by counsel for Patent Owner.
`
`/Bryan C. Diner/
`
`Bryan C. Diner, Lead Counsel
`Registration No. 32,409
`Justin J. Hasford, Backup Counsel
`Registration No. 62,180
`Finnegan, Henderson, Farabow, Garrett
`& Dunner, LLP
`901 New York Avenue NW
`Washington, DC 20001
`
`
`
`Date: October 22, 2015
`
`
`
`By:
`
`
`
`2
`
`
`
`Case IPR2015-00902 (Patent 8,669,290 B2)
`Case IPR2015-00903 (Patent 8,129,431 B2)
`
`Attorneys for Patent Owner Senju
`Pharmaceutical Co., Ltd.
`
`
`
`3
`
`
`
`
`
`
`
`Case IPR2015-00902 (Patent 8,669,290 B2)
`Case IPR2015-00903 (Patent 8,129,431 B2)
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing PATENT
`
`
`
`
`
`OWNER’S NOTICE OF CROSS-EXAMINATION OF DR. PAUL A. LASKAR,
`
`PH.D. was served on October 22, 2015, via email directed to counsel of record for
`
`the Petitioner at the following:
`
`Jitendra Malik, Ph.D
`Jitty.malik@alston.com
`
`Bryan Skelton, Ph.D.
`Bryan.skelton@alston.com
`
`Lance Soderstrom
`Lance.soderstrom@alson.com
`
`
`
`
`/Bradley J. Moore/
`Bradley J. Moore
`Litigation Clerk
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`
`
`
`4